thalidomide has been researched along with Benign Mucosal Pemphigoid in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duong, DJ | 1 |
Moxley, RT | 1 |
Kellman, RM | 1 |
Pincus, SH | 1 |
Gaspari, AA | 1 |
Singer, NG | 1 |
McCune, WJ | 1 |
1 review available for thalidomide and Benign Mucosal Pemphigoid
Article | Year |
---|---|
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cycl | 1998 |
1 other study available for thalidomide and Benign Mucosal Pemphigoid
Article | Year |
---|---|
Thalidomide therapy for cicatricial pemphigoid.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatologic Agents; Humans; Immunosuppressi | 2002 |